Related Experiment Video
Updated: Jan 26, 2026

Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
Posttransplantation Anemia in Kidney Transplant Recipients
Anat Gafter-Gvili1,2,3, Uzi Gafter4,5
1Department of Medicine A, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel, anatga2@clalit.org.il.
Insights
Posttransplantation anemia (PTA) is common in kidney transplant recipients, often caused by iron deficiency. Early treatment is crucial for improving graft survival and patient outcomes.
Area of Science:
- Nephrology
- Transplantation Medicine
- Hematology
Background:
- Posttransplantation anemia (PTA) is a frequent complication in kidney transplant recipients.
- PTA is categorized as early (within 6 months) or late (after 6 months) post-transplant.
- Iron deficiency is a primary cause of PTA, impacting graft function and survival.
Purpose of the Study:
- To review the causes, consequences, and management of posttransplantation anemia.
- To emphasize the importance of early detection and intervention for PTA.
- To define optimal hemoglobin targets and treatment strategies for anemic kidney transplant patients.
Main Methods:
- Literature review of studies on posttransplantation anemia.
- Analysis of the association between PTA and graft function, survival, and mortality.
- Evaluation of treatment guidelines for PTA, including hemoglobin targets and therapeutic agents.
Main Results:
- Late PTA is linked to diminished graft function, while early PTA predicts late onset.
- PTA is associated with increased mortality, reduced graft survival, and declining GFR.
- Optimal hemoglobin targets for kidney transplant recipients with anemia are higher (12.5-13 g/dL) than in general CKD patients.
Conclusions:
- Prompt treatment of PTA is recommended post-kidney transplantation.
- Treatment should involve erythropoiesis-stimulating agents (ESA) and iron supplementation to reach target hemoglobin levels.
- Effective PTA management is vital for improving long-term outcomes in kidney transplant recipients.
Abstract:
Posttransplantation anemia (PTA) is common among kidney transplant patients. Early PTA is usually defined as anemia which develops up to 6 months after transplantation, and late PTA is defined as anemia which develops after 6 months. There are multiple causes, with iron deficiency being the major contributor. The occurrence of late PTA has been associated with impaired graft function. Early PTA has been shown to be a predictor of late PTA. PTA is associated with reduced mortality, reduced graft survival, and a decline in GFR. The association with mortality is related to the severity of the anemia and to specific causes of anemia. Treatment of PTA should probably begin as soon as possible after kidney transplantation. The optimal target hemoglobin level in kidney transplant recipients with anemia is higher than recommended in chronic kidney disease and should probably be up to 12.5-13 g/dL. In order to achieve this target, appropriate treatment with erythropoiesis-stimulating agents (ESA) and iron is indicated.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Kidney Structure
External Anatomy of the Kidney
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
Internal Anatomy of the Kidney
Anatomical Position and Dimensions
The kidneys are retroperitoneal organs positioned against the posterior abdominal wall on either side of the spine, roughly between the twelfth thoracic and third lumbar vertebrae. Each kidney is typically 10-12 cm long, 5-6 cm wide, and 3-4 cm thick, weighing about 150 grams.
Renal Cortex
The outermost region of the kidney is the...

